ArticleNeoplasia (New York, N.Y.)2013

IGFBP-4 anti-angiogenic and anti-tumorigenic effects are associated with anti-cathepsin B activity.

María J Moreno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.